/entrackr/media/media_files/2025/06/17/G2Am2u62GV9ab8aH9wr2.png)
Quadria Group, a healthcare-focused private equity platform, has announced the launch of HealthQuad Fund III with a proposed raise of up to $300 million (target corpus of $200 million and a $100 million greenshoe option).
As the successor to Funds I and II, the third fund aims to build on a proven track record of identifying and scaling pioneering healthcare ventures that have significantly expanded access, affordability, and quality of care across India. The launch aligns with Quadria’s long-term vision of creating India’s most integrated healthcare investment platform, offering capital solutions from early-stage innovation to scaled growth across the healthcare value chain.
Launched in 2016, HealthQuad was initiated as a distinct investment vehicle focused on supporting disruptive, tech-enabled healthcare models at the early-growth stage. Funds I and II backed over 18 companies, including Qure.ai, Medikabazaar, THB, Wysa, Ekincare, Redcliffe Labs, GoApptiv, and Strand Life Sciences.
With Fund III, Quadria takes a step toward establishing a broader healthcare investment franchise. Dr. Amit Varma, Abrar Mir, and Sunil Thakur will assume full ownership and control of the platform following its separation from KOIS. A significant portion of the existing investment and committee team will remain involved in managing current portfolio investments.
Quadria intends to leverage its global and domestic institutional investor network to support the fund and create scaled impact. The firm recently closed Quadria Capital Fund III at $1.07 billion, backed by leading global institutions.
Founded in 2012, Quadria Capital manages over $4 billion in assets across 27 investments in South and Southeast Asia, including India, Vietnam, Indonesia, Malaysia, and Singapore. The firm aims to generate sustainable value by partnering with high-impact healthcare businesses and delivering strong investor returns.